tiprankstipranks
Trending News
More News >
InnovAge Holding (INNV)
NASDAQ:INNV
US Market
Advertisement

InnovAge Holding (INNV) Earnings Dates, Call Summary & Reports

Compare
51 Followers

Earnings Data

Report Date
Feb 10, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.04
Last Year’s EPS
-0.1
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance with significant revenue and EBITDA growth, a record census, and positive net income. However, challenges persist in the operating environment with increased costs and leadership transitions.
Company Guidance
During the InnovAge First Quarter 2026 Earnings Conference Call, the company provided detailed guidance and metrics for the fiscal year. InnovAge reported a total revenue of $236.1 million for the quarter, reflecting a 15% increase compared to the first quarter of fiscal 2025, and an adjusted EBITDA of $17.6 million, more than doubling from the previous year. The census grew to an all-time high of 7,890 participants, marking a nearly 2% quarter-over-quarter increase. The call highlighted strong medical cost management and better-than-expected census growth. InnovAge reaffirmed its fiscal year 2026 guidance with expected total revenue between $900 million and $950 million, and adjusted EBITDA in the range of $56 million to $65 million. The company also outlined operational changes, including leadership transitions and efforts to streamline support functions, aiming to enhance efficiency and align cost structure with best-in-class benchmarks.
Revenue and Adjusted EBITDA Growth
Total revenue for Q1 2026 was $236.1 million, a 15% increase compared to Q1 2025. Adjusted EBITDA more than doubled to $17.6 million from the previous year.
Record Census and Participant Growth
The census grew to an all-time high of 7,890 participants, reflecting a 9.4% increase year-over-year and a 1.9% increase quarter-over-quarter.
Positive Net Income and Improved Margins
Net income was $7.7 million, compared to a net loss of $5.7 million in Q1 2025. The center-level contribution margin increased to 21.8%, a rise of approximately 320 basis points from the previous quarter.
Successful In-House Pharmacy Transition
The transition to in-house pharmacy services contributed to reduced pharmacy expenses and improved cost management.
Leadership and Organizational Enhancements
New leadership appointments, including Dr. Paul Taheri as Chief Medical Officer and Meredith Delk as Chief Administrative Officer, aim to strengthen operations and continue organizational growth.

InnovAge Holding (INNV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

INNV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 10, 2026
2026 (Q2)
0.04 / -
-0.1
Nov 04, 2025
2026 (Q1)
0.02 / 0.06
-0.04250.00% (+0.10)
Sep 09, 2025
2025 (Q4)
-0.01 / -0.01
-0.010.00% (0.00)
May 06, 2025
2025 (Q3)
-0.01 / -0.08
-0.04-100.00% (-0.04)
Feb 04, 2025
2025 (Q2)
-0.01 / -0.10
-0.03-233.33% (-0.07)
Nov 05, 2024
2025 (Q1)
-0.04 / -0.04
-0.0850.00% (+0.04)
Sep 10, 2024
2024 (Q4)
-0.02 / -0.01
-0.0988.89% (+0.08)
May 07, 2024
2024 (Q3)
-0.04 / -0.04
-0.0520.00% (+0.01)
Feb 06, 2024
2024 (Q2)
-0.03 / -0.03
-0.0757.14% (+0.04)
Nov 07, 2023
2024 (Q1)
-0.04 / -0.08
-0.120.00% (+0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

INNV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$4.84$3.99-17.56%
Sep 09, 2025
$4.27$4.15-2.81%
May 06, 2025
$2.85$3.26+14.39%
Feb 04, 2025
$3.69$3.36-8.94%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does InnovAge Holding (INNV) report earnings?
InnovAge Holding (INNV) is schdueled to report earning on Feb 10, 2026, After Close (Confirmed).
    What is InnovAge Holding (INNV) earnings time?
    InnovAge Holding (INNV) earnings time is at Feb 10, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is INNV EPS forecast?
          INNV EPS forecast for the fiscal quarter 2026 (Q2) is 0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis